AIRLINK 74.81 Decreased By ▼ -0.44 (-0.58%)
BOP 5.13 Increased By ▲ 0.02 (0.39%)
CNERGY 4.49 Decreased By ▼ -0.11 (-2.39%)
DFML 33.30 Increased By ▲ 0.77 (2.37%)
DGKC 89.21 Decreased By ▼ -1.14 (-1.26%)
FCCL 22.65 Decreased By ▼ -0.33 (-1.44%)
FFBL 32.80 Decreased By ▼ -0.77 (-2.29%)
FFL 9.89 Decreased By ▼ -0.15 (-1.49%)
GGL 10.92 Decreased By ▼ -0.13 (-1.18%)
HBL 115.00 Increased By ▲ 0.10 (0.09%)
HUBC 136.48 Decreased By ▼ -0.86 (-0.63%)
HUMNL 9.90 Increased By ▲ 0.37 (3.88%)
KEL 4.61 Decreased By ▼ -0.05 (-1.07%)
KOSM 4.73 Increased By ▲ 0.03 (0.64%)
MLCF 39.88 Decreased By ▼ -0.66 (-1.63%)
OGDC 140.00 Increased By ▲ 0.25 (0.18%)
PAEL 27.35 Decreased By ▼ -0.30 (-1.08%)
PIAA 24.95 Increased By ▲ 0.55 (2.25%)
PIBTL 6.78 Decreased By ▼ -0.14 (-2.02%)
PPL 123.56 Decreased By ▼ -1.74 (-1.39%)
PRL 27.20 Decreased By ▼ -0.35 (-1.27%)
PTC 14.02 Decreased By ▼ -0.13 (-0.92%)
SEARL 59.20 Decreased By ▼ -2.65 (-4.28%)
SNGP 71.70 Decreased By ▼ -1.28 (-1.75%)
SSGC 10.45 Decreased By ▼ -0.14 (-1.32%)
TELE 8.69 Decreased By ▼ -0.09 (-1.03%)
TPLP 11.52 Decreased By ▼ -0.21 (-1.79%)
TRG 65.50 Decreased By ▼ -1.10 (-1.65%)
UNITY 25.76 Increased By ▲ 0.61 (2.43%)
WTL 1.39 Decreased By ▼ -0.05 (-3.47%)
BR100 7,823 Increased By 20.3 (0.26%)
BR30 25,605 Decreased By -210.2 (-0.81%)
KSE100 74,714 Increased By 182.9 (0.25%)
KSE30 24,075 Increased By 121.1 (0.51%)

ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has sought feedback from the public and relevant stakeholders to finalise guidelines for hospital pharmacies.

According to DRAP, these standards are aimed at ensuring consistent, high-quality pharmacy services across the country in public and private hospitals, ultimately, benefiting patients and the healthcare system as a whole.

The public announcement stated: DRAP invites you to review the proposed guidelines and share your thoughts and suggestions. Your input will be invaluable in shaping the final document and ensuring it reflects the needs and expectations of patients, healthcare professionals, and the community.

The DRAP is to set hospital pharmacy guidelines in following four key areas: (i) Hospital Pharmacy Operations which include aspects like organizational structure, staffing, resources, policies, and procedures for managing medications from procurement and storage to dispensing and monitoring.

(ii) Medicine Use Management where the focus is on optimizing medication use within the hospital. This involves procedures for medication reconciliation, identifying potential issues, and implementing strategies to improve medication effectiveness and avoid medication-related harm.

(iii) Quality Improvement with believe in continuous improvement! These guidelines outline practices for assessing the effectiveness of hospital pharmacy services, identifying areas for improvement, and implementing corrective actions.And,

(iv) Human Resources Development for ensuring a competent and skilled pharmacy workforce is crucial. The guidelines address training and development programmes for all pharmacy personnel, from pharmacists to technicians. However, the health regulator has not given any timeline for the proposals.

Copyright Business Recorder, 2024

Comments

Comments are closed.